U.S. FDA gives early approval to Sarepta's DMD gene therapy

FILE PHOTO: The headquarters of the U.S. Food and Drug Administration (FDA) is seen in Silver Spring, Maryland November 4, 2009. REUTERS/Jason Reed/File Photo

(Reuters) – The U.S. Food and Drug Administration on Thursday granted an early approval to Sarepta Therapeutics Inc’s gene therapy for Duchenne muscular dystrophy (DMD).

DMD is a rare, genetic disorder that hampers muscle movement mainly in men, affecting one in every 3,500 to 5,000 males.

It can cause life-threatening damage to the heart, and over time, death, often at a young age.

Reporting by Dania Nadeem in Bengaluru; Editing by Sriraj Kalluvila

Our Standards:The Thomson Reuters Trust Principles.

source: reuters.com

🕐 Top News in the Last Hour By Importance Score

#	Title	📊 i-Score
1	Air pollution now linked to another health condition… after studies reveal it could cause autism and cancer	🔴 78 / 100
2	Ronin the rat sets new landmine-sniffing record	🔴 75 / 100
3	Mach CEO on building defense tech company in your 20s	🔴 75 / 100
4	Meta whistleblower’s testimony will show if Mark Zuckerberg, other execs ‘lied to Congress’ about China ties: Sen. Hawley	🔴 75 / 100
5	Trump Extends Deadline for a TikTok Deal	🔴 75 / 100
6	Mother of football star knifed to death bursts into tears on live TV and sends message to murderer	🔴 72 / 100
7	Prince Andrew wrote birthday letters to Xi Jinping, ex-adviser told court	🔴 72 / 100
8	Russell Brand’s Net Worth: How Much Money the Comedian Has Now	🔴 65 / 100
9	Cash Isa rates hiked as high as 5.92% by Plum, Chip and CMC: Which is the new best buy?	🔵 60 / 100
10	Afghan's claim he is 140 years old – making him the oldest person EVER to have lived – is investigated by the Taliban	🔵 45 / 100

View More Top News ➡️